Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.11.18 (
MAP
)
7,412
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We characterized a highly purified preparation of the chromosomally encoded dihydrofolate reductase (DHFR) from a trimethoprim-susceptible (Tmp8; strain
MAP
) and two trimethoprim-resistant (TmpR) strains (
MAP
/47 and
MAP
/42) of Haemophilus influenzae. The enzymes were purified between 650- and 3000-fold by gel-filtration and dye-ligand chromatography. The apparent molecular mass of the three proteins was 18400 Da by PAGE under denaturing and nondenaturing conditions. Total enzyme activity was greater in all fractions from the TmpR strains compared with the Tmp8 isolate. The three enzymes had a similar Km for
dihydrofolate
(7, 9 and 5 microM) and NADPH (2, 5 and 6 microM). However, the Tmp IC50 (the concentration necessary for 50% inhibition of DHFR activity) for the Tmp8 strain
MAP
was 0.001 microM, whereas DHFR from the TmpR strains
MAP
/47 and
MAP
/42 had values of 0.1 microM and 0.3 microM respectively. The methotrexate IC50 of the
MAP
/42 DHFR was 0.06 microM in comparison with the enzyme from
MAP
(0.008 microM) and
MAP
/47 (0.007 microM). Isoelectric focusing indicated that the DHFR from
MAP
/42 had a different isoelectric point (pI 7.6) compared with the enzymes from
MAP
and
MAP
/47 (pI 7.3). Peptide mapping after digestion with trypsin revealed one major peptide fragment (7.9 kDa) in the DHFR of
MAP
and
MAP
/47 and three major tryptic fragments (7.9, 9.6 and 12.5 kDa) in DHFR from
MAP
/42. We conclude that trimethoprim resistance in H. influenzae results from overproduction of structurally altered DHFR(s).
...
PMID:Trimethoprim resistance in Haemophilus influenzae is due to altered dihydrofolate reductase(s). 201 95
Chinese hamster dihydrofolate reductase (ch-DHFR) was overexpressed in Escherichia coli DH5 alpha under the transcriptional control of PRPL promoters regulated by temperature-sensitive repressors. The desired recombinant product is soluble and constitutes about 30% of the total soluble proteins of the bacterial cell. With repeated cycles of freezing and thawing as a first step, the purification of the recombinant ch-DHFR to homogeneity requires only one further step, gel filtration on a Sephadex G-75 column with 85-90% enzyme recovery, two to three times higher than that obtained with the commonly used affinity chromatography on a methotrexate-Sepharose column. The purified enzyme migrates as a single protein band on SDS-polyacrylamide gel electrophoresis with approximate mass of 23 kDa, in accord with that calculated from the DNA sequence. The initiation methionine residue at the N-terminus of the enzyme is completely removed by E. coli
methionine aminopeptidase
as judged by amino-terminal analysis. The steady-state kinetic parameters, dissociation constants for binary complexes of
dihydrofolate
, NADPH, and methotrexate with ch-DHFR, and the inhibitor constant of methotrexate have also been determined. The enzyme is activated about 4-fold in 3 M urea and about 2.5-fold in 0.5 M guanidine hydrochloride.
...
PMID:Soluble expression in Escherichia coli, one-step purification, and characterization of Chinese hamster dihydrofolate reductase. 905 90